Author

Weifei Ye

Institution: Eisai (United States)

Observed institution: Eisai (United States)

OpenAlex ID: A5063394298

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer

2021 · Lori J. Wirth, Marcia S. Brose, et al. · Journal of Clinical Oncology · 131

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

2021 · Thomas E. Hutson, M. Dror Michaelson, et al. · European Urology · 89

MON-521 An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib (LEN) for the Treatment of Anaplastic Thyroid Cancer (ATC)

2020 · Lori J Wirth, Marcia S Brose, et al. · Journal of the Endocrine Society · 4

Works count: 3

Citation count: 224

H-index: 3

I10-index: 2